COVID-19 Vaccines Current State and Perspectives
COVID-19 Vaccines - Current State and Perspectives provides the reader with the latest overview and opinions on the current state of the art in COVID-19 vaccines, as well as future prospects. The challenges covered include novel vaccine development for the emerging variants of concern (VOCs), vaccin...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_113236 | ||
| 005 | 20230905 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230905s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a intechopen.101006 | ||
| 020 | |a 9781803553580 | ||
| 020 | |a 9781803553573 | ||
| 020 | |a 9781803553597 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.5772/intechopen.101006 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MBNS |2 bicssc | |
| 100 | 1 | |a Abdurakhmonov, Ibrokhim Y. |4 edt | |
| 700 | 1 | |a Abdurakhmonov, Ibrokhim Y. |4 oth | |
| 245 | 1 | 0 | |a COVID-19 Vaccines |b Current State and Perspectives |
| 260 | |b IntechOpen |c 2023 | ||
| 300 | |a 1 electronic resource (160 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a COVID-19 Vaccines - Current State and Perspectives provides the reader with the latest overview and opinions on the current state of the art in COVID-19 vaccines, as well as future prospects. The challenges covered include novel vaccine development for the emerging variants of concern (VOCs), vaccine side-effects with real-world examples, population hesitancy, and country experiences with COVID-19 vaccine development, clinical trialing and mass vaccination. Chapters discuss new opinions and directions on the repurposing of existing traditional vaccines with a wide spectrum of action and new platforms for fast-tracked vaccine production and approvals. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Epidemiology & medical statistics |2 bicssc | |
| 653 | |a sars-cov-2 | ||
| 653 | |a malaria | ||
| 653 | |a clinical trials | ||
| 653 | |a vaccination | ||
| 653 | |a coronavirus | ||
| 653 | |a tuberculosis | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/11724/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/113236 |7 0 |z DOAB: description of the publication |